Cyclomydril side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Cyclomydril. Common side effects include apnoea among females and apnoea among males.

The phase IV clinical study is created by eHealthMe based on 73 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 28, 2022

73 people who take Cyclomydril and have side effects are studied.


What is Cyclomydril?

Cyclomydril has active ingredients of cyclopentolate hydrochloride; phenylephrine hydrochloride. eHealthMe is studying from 73 Cyclomydril users for its effectiveness, alternative drugs and more.

Number of Cyclomydril reports submitted per year:

Cyclomydril side effects.

Cyclomydril side effects by time on the drug*:

< 1 month:

  1. Apnoea (suspension of external breathing)
  2. Retinopathy of prematurity (retina damage in premature)
  3. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  4. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  5. Abdominal distension
  6. Oxygen saturation decreased
  7. Bradycardia (abnormally slow heart action)
  8. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Hypopnoea (decrease in the breathing rate)

1 - 6 months:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Vomiting
  2. Apnoea (suspension of external breathing)
  3. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  4. Inflammation
  5. Drug ineffective
  6. Abdominal distension
  7. Adverse event
  8. Apnoeic attack
  9. Blood pressure increased
  10. Corneal opacity (scarring or clouding of the cornea)

Cyclomydril side effects by gender *:

female:

  1. Apnoea (suspension of external breathing)
  2. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  3. Inflammation
  4. Abdominal distension
  5. Apnoeic attack
  6. Bradycardia (abnormally slow heart action)
  7. Drug ineffective
  8. Glare (difficulty seeing in the presence of bright light)
  9. Hypopnoea (decrease in the breathing rate)
  10. Instillation site pain

male:

  1. Apnoea (suspension of external breathing)
  2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  3. Streptococcus test positive
  4. Oxygen saturation decreased
  5. Blood pressure increased
  6. Corneal opacity (scarring or clouding of the cornea)
  7. Endophthalmitis (inflammation of the internal coats of the eye)
  8. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  9. Intestinal perforation (complete penetration of the wall of the intestine)
  10. Retinopathy of prematurity (retina damage in premature)

Cyclomydril side effects by age (0-1 to 60+) *:

0-1:

  1. Apnoea (suspension of external breathing)
  2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  3. Oxygen saturation decreased
  4. Abdominal distension
  5. Apnoeic attack
  6. Blood pressure increased
  7. Bradycardia (abnormally slow heart action)
  8. Corneal opacity (scarring or clouding of the cornea)
  9. Hypopnoea (decrease in the breathing rate)
  10. Intestinal perforation (complete penetration of the wall of the intestine)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

40-49:

n/a

50-59:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)

60+:

  1. Endophthalmitis (inflammation of the internal coats of the eye)
  2. Instillation site pain
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Streptococcus test positive
  5. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  6. Inflammation

* Approximation only. Some reports may have incomplete information.

Do you take Cyclomydril?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on cyclopentolate hydrochloride; phenylephrine hydrochloride (the active ingredients of Cyclomydril) and Cyclomydril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Cyclomydril:

All Cyclomydril side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: